Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur

Journal of Bone and Mineral Research

Volumn 29, Issue 4, 2014, Pages 999-1004

  Zanchetta, Maria Belen ^a   Diehl, Maria ^b   Buttazzoni, Mirena ^b   Galich, Ana ^b   Silveira, Fernando ^a   Bogado, Cesar E ^a   Zanchetta, Jose Rubén ^a  

^a UNIVERSIDAD DEL SALVADOR   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

ATYPICAL FEMORAL FRACTURES; BONE MICROARCHITECTURE; FEMORAL SHAFT FRACTURE; HR PQCT; LONG TERM BISPHOSPHONATE TREATMENT

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT;

AGE; AGED; ARTICLE; ATYPICAL FEMORAL FRACTURE; BODY MASS; BONE DENSITY; BONE MASS; BONE MICROARCHITECTURE; BONE STRUCTURE; CASE CONTROL STUDY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DETERIORATION; FEMALE; FEMUR FRACTURE; FEMUR NECK; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RESOLUTION PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY; HUMAN; LONG TERM CARE; LUMBAR SPINE; OBSERVATIONAL STUDY; OSTEOPENIA; OSTEOPOROSIS; PATHOPHYSIOLOGY; POSTMENOPAUSE; RADIUS; SCORING SYSTEM; TIBIA; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; DIPHOSPHONATES; FEMALE; FEMORAL FRACTURES; HUMANS; MIDDLE AGED; POSTMENOPAUSE;

EID: 84897908743     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2107     Document Type: Article

References (31)

1. Schilcher J, Michaelsson K, Aspenberg P., Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011 May 5; 364 (18): 1728-37.
2. Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2010; 25: 2267-94.
3. Rizzoli R, Akesson K, Bouxsein M, et al. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation working group report. Osteoporos Int. 2011 Feb; 22 (2): 373-90.
4. Compston J., Pathophysiology of atypical femoral fractures and osteonecrosis of the jaw. Osteoporos Int. 2011; 22: 2951-61.
5. Nieves J, Cosman F., Atypical subtrochanteric and femoral shaft fractures and possible association with bisphosphonates. Curr Osteoporos Rep. 2010; 8: 34-9.
6. Sellmeyer DE., Atypical fractures as a potential complication of long term bisphosphonate therapy. JAMA. 2010 Oct 6; 304 (13): 1480-4.
7. Park-Wyllie LY, Mamdani MM, Juurlink DN, et al. Bisphosphonate use, the risk of subtrochanteric or femoral shaft fractures in older women. JAMA. 2011 Feb 23; 305 (8): 783-9.
8. Yli-Kyyny TT, Tamminen I, Kroger H., Atraumatic bilateral femur fracture in long-term bisphosphonate use. Orthopedics. 2010 Dec; 33 (12): 867.
9. Black DM, Kelly MP, Genant HK., et al. Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. Bisphosphonates and fractures of the subtrochanteric or diaphyseal femur. N Engl J Med. 2010 May 13; 362 (19): 1761-171.
10. Girgis CM, Sher D, Seibel MJ., Atypical femoral fractures and bisphosphonate use. N Engl J Med. 2010 May 13; 362 (19): 1848-9.
11. Giusti A, Hamdy NA, Papapoulos SE., Atypical fractures of the femur and bisphosphonate therapy: a systematic review of case/case series studies. Bone. 2010 Aug; 47 (2): 169-80.
12. Abrahamsen B, Eiken P, Eastell R., Subtrochanteric and diaphyseal femur fractures in patients treated with alendronate: a register-based national cohort study. J Bone Miner Res. 2009 Jun; 24 (6): 1095-102.
13. Laib A, Hauselmann HJ, Ruegsegger P., In vivo high resolution 3DQCT of the human forearm. Technol Health Care. 1998; 6: 329-37.
14. Laib A, Ruegsegger P., Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. Bone. 1999; 24 (1): 35-9.
15. Hildebrand T, Laib A, Muller R, Dequeker J, Ruegsegger P., Direct three-dimensional morphometric analysis of human cancellous bone: microstructural data from spine, femur, iliac crest, and calcaneus. J Bone Miner Res. 1999; 14: 1167-74.
16. MacNeil JA, Boyd SK., Accuracy of high-resolution peripheral quantitative computed tomography for measurement of bone quality. Med Eng Phys. 2007; 29: 1096-105.
17. Liu XS, Zhang XH, Sekhon KK, et al. Calibration of trabecular bone structure measurements of in vivo three-dimensional peripheral quantitative computed tomography with 28-microm-resolution microcomputed tomography. J Bone Miner Res. 2010; 25 (4): 746-56.
18. Melton LJ 3rd, van Lenthe GH, Achenbach SJ, et al. Contribution of in vivo structural measurements and load/strength ratios to the determination of forearm fracture risk in postmenopausal women. J Bone Miner Res. 2007; 22: 1442-8.
19. Walker MD, McMahon DJ, Udesky J, Liu G, Bilezikian JP., Application of high-resolution skeletal imaging to measurements of volumetric BMD and skeletal microarchitecture in Chinese-American and white women: explanation of a paradox. J Bone Miner Res. 2009; 24: 1953-9.
20. Silveira F, Monteverde C, Ripero V, et al. Reproducibility of HR-pQCT measurements in women with normal BMD and postmenopausal women with osteoporosis. Abstracts of the First IOF-ESCEO Pre-Clinical Symposium and the ECCEO11-IOF Congress. March 22-23, 2011. Valencia, Spain. Osteoporos Int. 2011; 22 Suppl 1:S43-44; S254-5.
21. Sornay-Rendu E, Boutroy S, Munoz F, Delmas PD., Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: The OFELY study. J Bone Miner Res. 2007; 22: 425-33.
22. Sornay-Rendu E, Cabrera-Bravo JL, Boutroy S, Munoz F, Delmas PD., Severity of vertebral fractures is associated with alterations of cortical architecture in postmenopausal women. J Bone Miner Res. 2009; 24: 737-43.
23. Vico L, Zouch M, Amirouche A, et al. High-resolution pQCT analysis at the distal radius and tibia discriminates patients with recent wrist and femoral neck fractures. J Bone Miner Res. 2008; 23: 1741-50.
24. Stein EM, Liu XS, Nickolas TL, et al. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res. 2010; 25: 2572-81.
25. Stein EM, Liu XS, Nickolas TL, et al. Microarchitectural abnormalities are more severe in postmenopausal women with vertebral compared to nonvertebral fractures. J Clin Endocrinol Metab. 2012 Oct; 97 (10): E1918-26.
26. Zanchetta MB, Sesta M, Silveira F, Bogado C, Massari F, Zanchetta JR., High-resolution peripheral quantitative computerized (HR-pQCT) but not DXA discriminates between postmenopausal women with and without fragility fractures. J Bone Miner Res. 2009; 24 Suppl 1. [Poster session presented at: 31st Annual Meeting American Society for Bone and Mineral Research (ASBMR); 2009 Sep 1-13; Denver, CO, USA; Presentation Number: MO0279]. Available at http://www.asbmr. org/Meetings/AnnualMeeting/AbstractDetail.aspx?aid=a72c580a-0b37-4628-87b3- df8f12a6c7ac
27. Paparodis R, Buehring B, Pelley E, Binkley N., A case of an unusual subtrochanteric fracture in a patient receiving denosumab. Endocr Pract. 2013 Jan 21: 1-17.
28. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Index to drug-specific information [Internet]. Silver Spring (MD): U.S. Food and Drug Administration; 2010. [updated 2013 Aug 23; cited 2013 Nov 18]. Available from: http://www.accessdata.fda.gov/scripts/cder/drugsatfda/ index.cfm?fuseaction=Search.Set-Current-Drug&ApplNo=125320&DrugName= PROLIA&ActiveIngred=DENOSUMAB&SponsorApplicant=AMGEN& ProductMktStatus=1&goto=Search.Label-ApprovalHistory
29. Bala Y, Farlay D, Chapurlat RD, Boivin G., Modifications of bone material properties in postmenopausal osteoporotic women long-term treated with alendronate. Eur J Endocrinol. 2011 Oct; 165 (4): 647-55.
30. Güerri R, Nogues X, Cáceres E, et al. Microindentation for in vivo measurement of bone tissue material properties in atypical femoral fracture patients and controls. J Bone Miner Res. 2013 Jan; 28 (1): 162-8.
31. Tamminen IS, Yli-Kyyny T, Isaksson H, et al. Incidence and bone biopsy findings of atypical femoral fractures. J Bone Miner Metab. 2013 Sep; 31 (5): 585-94.